Delivery Order SPE2DB22D3501-SPE2DB24FUT51
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The contract is for the supply of Spikevax COVID-19 vaccine syringes (0.5 mL) for individuals aged 12 years and older. The potential value of this delivery order is $4,662.90, with a completion date of February 20, 2024. The contract does not have a set-aside designation....
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $11,657.25 contract is for the delivery of SPIKEVAX COVID-19 vaccine syringes (0.5mL) for individuals 12 years and older. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,416.00, is for the procurement of SPIKEVAX 2024-25 (12Y UP) SYRG 0.5ML, which are likely COVID-19 vaccine syringes. The contract has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,672.00, is for the procurement of SPIKEVAX COVID-19 vaccine syringes (0.5ML) for individuals 12 years and older. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a $4,662.90 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the procurement of SPIKEVAX COVID-19 vaccine syringes, 0.5 mL, for use by those aged 12 and up. The order does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distribution company that holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a $8,526.60 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the provision of SPIKEVAX COVID-19 vaccine syringes (0.5 ml) to support military treatment programs and facilities. The delivery order was not set aside and is expected to be completed by January 11, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous...
- The Defense Logistics Agency (DLA) awarded a $70,925.00 firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of SPIKEVAX (COVID-19 vaccine) syringes (0.5 mL) with a completion date of February 21, 2024. This award is part of a larger single-award indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver pharmaceutical products and...
- This is a federal contract award valued at $1,383.94, issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of SPIKEVAX COVID-19 vaccine syringes, 0.5 ml, for individuals 12 years and older. The contract is a firm fixed-price delivery order awarded on May 29, 2024, with a completion date of June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIKEVAX COVID-19 vaccine syringes (0.5 mL) for individuals aged 12 and above. The contract has a ceiling value of $13,971.40 and an ultimate completion date of September 18, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SPIKEVAX COVID-19 vaccine syringes valued at $6,919.70. This contract has an ultimate completion date of July 12, 2024 and is a firm fixed-price arrangement. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the primary...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUT51Delivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the supply of SPIKEVAX COVID-19 vaccine syringes in 0.5 mL doses for individuals 12 years and older. The total potential value of the order is $7,771.50, with a completion date of March 21, 2024. This order is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The company also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division for medical supplies and prescription medications, valued at up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 2/29/24 |